<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-2022-jp">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:DengXian;
        panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Aptos;
        panose-1:2 11 0 4 2 2 2 2 2 4;}
@font-face
        {font-family:Cambria;
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:"\@DengXian";
        panose-1:2 1 6 0 3 1 1 1 1 1;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        font-size:12.0pt;
        font-family:"Aptos",sans-serif;
        mso-ligatures:standardcontextual;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#467886;
        text-decoration:underline;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;
        mso-ligatures:none;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
/* List Definitions */
@list l0
        {mso-list-id:8607886;
        mso-list-template-ids:626970806;}
@list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level2
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:1.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:1.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:2.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level5
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:2.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:3.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:3.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level8
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:4.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l0:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:4.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1
        {mso-list-id:338506858;
        mso-list-template-ids:320777316;}
@list l1:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level2
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:1.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:1.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:2.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level5
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:2.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:3.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:3.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level8
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:4.0in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
@list l1:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7 ;
        mso-level-tab-stop:4.5in;
        mso-level-number-position:left;
        text-indent:-.25in;
        mso-ansi-font-size:10.0pt;
        font-family:Symbol;}
ol
        {margin-bottom:0in;}
ul
        {margin-bottom:0in;}
--></style>
</head>
<body lang="EN-US" link="#467886" vlink="#96607D" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Dear Faculty Affiliates,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">I hope this email finds you well.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">I am writing to you today to share an exciting opportunity to develop a proposal for the
<b>Advanced Research Projects Agency for Health (ARPA-H) Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) program</b>. This program has released an Innovative Solutions Opening Solicitation with a focus on developing
<b>AI/ML-enabled in silico human physiology modeling platforms for ADME-Tox simulation to replace the poorly predictive investigational new drug (IND) IND-enabling preclinical animal studies currently used</b>.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">This initiative aligns perfectly with our institute's mission to promote successful longevity and could significantly impact the field of drug discovery
 for Alzheimer’s disease and related dementia (and co-occurring conditions related to ADRD). The goal of the CATALYST program is to reduce drug development costs and timelines while increasing the success rate of clinical trials through accurate prediction
 of the safety, toxicity, and availability of therapeutic candidates.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">The program is structured in two phases:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Phase I: Accelerated Technology Development and Method Qualification (36 months)</span></b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">:
 Focuses on developing technologies that meet the in silico predictive goals of CATALYST through three technical areas (TAs):<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">○
<b>TA1</b>: Data discovery methods and predictive drug safety models4<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">○
<b>TA2</b>: Living systems tools for model development4<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">○
<b>TA3</b>: In silico simulation-based human physiology models4<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Phase II: COU Concept Demonstration and Methodology Adoption (18 months)</span></b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">:
 Drug developers pursue regulatory filings using the in silico platform developed in Phase I.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">To ensure the success of this endeavor, we need a strong team with expertise in various areas, including data discovery, living systems tools, in silico
 modeling, and drug development. I am reaching out to gauge your interest in joining a discussion about developing a proposal for this opportunity.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">I am particularly interested in hearing from faculty affiliates with expertise in ADRD and those with a strong background in AI/ML and computational modeling.
 The sources mention a few specific areas of expertise:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Cheminformatics<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Genomics<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Proteomics5<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Toxicological data<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Systems biology, including physiological data<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Preclinical study<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">● Clinical study and data (EHR)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Please let me know if you are interested in learning more about this opportunity and potentially joining our team by Thursday 11/7. We have scheduled a Zoom
 meeting at 11:30 AM on 11/7 to discuss the program in detail and explore potential collaborations. The pre-proposal (4-page) is due on 11/25 so the timeline is quite tight.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Thank you for
</span><span style="font-size:11.0pt;mso-ligatures:none">your time and consideration!<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none">Attached please find the ARPA-H CATALYST solicitation.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;color:#212121">CATALYST Proposers’ Day Resources:</span><span style="font-size:11.0pt;color:#212121;mso-ligatures:none"><o:p></o:p></span></p>
<ul style="margin-top:0in;caret-color: rgb(33, 33, 33);font-variant-caps: normal;orphans: auto;text-align:start;widows: auto;-webkit-text-stroke-width: 0px;word-spacing:0px" type="disc">
<li class="MsoNormal" style="color:#212121;mso-list:l0 level1 lfo2"><span style="font-size:11.0pt"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dx4zVNeSYcvk&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946428597%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=3wXoRV98cFUI1pyQa6%2BOJdr0yd0wcbgTN0Ke46MjXds%3D&reserved=0" originalsrc="https://www.youtube.com/watch?v=x4zVNeSYcvk" shash="L5CpJdks95+sX9yyV8WXHa0zKwwsXspElK5QuJ/GeEr8yX5azCeSBamQytLaacERl/fsMR+aBxSR2PzKVuFZcj7kv27hBcMDVsAgtc1V97pWu+63Y9nF8BGCxIGmnmAEPdUB/4+do+PyZwFtLqrh4s9wPr7RqOGscRle2ASXfOY=" title="Original URL:
https://www.youtube.com/watch?v=x4zVNeSYcvk

Click to follow link."><span style="color:#0078D7">CATALYST
 Proposers’ Day recording</span></a><o:p></o:p></span></li><li class="MsoNormal" style="color:#212121;mso-list:l0 level1 lfo2"><span style="font-size:11.0pt"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Farpa-h.gov%2Fresearch-and-funding%2Fprograms%2Fcatalyst&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946428597%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=euNp%2FuMJMBRiQI%2F%2F1TPr5KgodIadZ5uWE8WK3zB5odo%3D&reserved=0" originalsrc="https://arpa-h.gov/research-and-funding/programs/catalyst" shash="shzCxSHSOlCqJCicFpx7PbNYlLb+CCOJNkQJfz6lGqNOu/CKWXFZIJrQiCbRqqlndeQrTThL5wArcAcooTt5gIUXuuKwFbzROE97lQ6jMCwty6VjtkPhSmzUpJ89veJOGGXmvb1IVyINYyHaxIOTxrry2hlYORThAr1I1dEH4Oo=" title="Original URL:
https://arpa-h.gov/research-and-funding/programs/catalyst

Click to follow link."><span style="color:#0078D7">CATALYST
 Program page</span></a><o:p></o:p></span></li><li class="MsoNormal" style="color:#212121;mso-list:l0 level1 lfo2"><span style="font-size:11.0pt"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Farpa-h.gov%2Fresearch-and-funding%2Fprograms%2Fcatalyst%2Fteaming&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946428597%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=L9DVXBpLCk7QeOzrN4O%2FwrbSAm%2Br7dkp7BpE4jniOFo%3D&reserved=0" originalsrc="https://arpa-h.gov/research-and-funding/programs/catalyst/teaming" shash="MjfwrVuSE+mSLKrIRGNc+utVhQttiFMWo1spk4SDJNSmIwAhulCoTOvXa6IiXLELyAt7S2wRtGIc65TxHWP8Uge4ilKHtXiOZ27Mgg1gHG8ETLgkIYCmjWDXDzJ+bQL8aajPi6MYSKlz8gIBU7V6pTQXG2D+gKzhtg1C/ubzr+U=" title="Original URL:
https://arpa-h.gov/research-and-funding/programs/catalyst/teaming

Click to follow link."><span style="color:#0078D7">CATALYST
 Teaming page</span></a><o:p></o:p></span></li><li class="MsoNormal" style="color:#212121;mso-list:l0 level1 lfo2"><span style="font-size:11.0pt"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fsam.gov%2Fopp%2F325e7a5a97124b6b9b4916818e88cb91%2Fview&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946428597%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=qCaRU0A%2BZDsCI8VgBCkyE8q%2BM1ZwkFJcMIcpFeLP7jw%3D&reserved=0" originalsrc="https://sam.gov/opp/325e7a5a97124b6b9b4916818e88cb91/view" shash="RmJ/sOQXymEQMOOoNakA2MA8H/ut6hMSTun9dOKGqcP9XzWDvDT1qW51Z+ehm1BL8DQIz55AVDM4juPCHFo4MZJeD4orCHCF3yUuhpfkY6WQw2lm3pXO2lPTDPjx7P9ood5Xdpi9HlJrefiVvhYuLIEpU9EoYFkCiKEj+evkKY0=" title="Original URL:
https://sam.gov/opp/325e7a5a97124b6b9b4916818e88cb91/view

Click to follow link."><span style="color:#0078D7">Innovative
 Solution Opening</span></a><o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:11.0pt;color:#212121"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;color:#212121">Our Office of Research staff also took some notes in the Proposer Day:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dropbox.com%2Fscl%2Ffi%2F0tf3fmjxvks2wv01gz4zu%2FARPA-H-CATALYST-Notes.docx%3Frlkey%3Du7cv91de7spjrbitzxrxqjark%26st%3Dkcj8b5br%26dl%3D0&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946584800%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=1wobkEfFJ6100NYX8qK6jl8JEseH4Jk49GQax1JuOYI%3D&reserved=0" originalsrc="https://www.dropbox.com/scl/fi/0tf3fmjxvks2wv01gz4zu/ARPA-H-CATALYST-Notes.docx?rlkey=u7cv91de7spjrbitzxrxqjark&st=kcj8b5br&dl=0" shash="idZBmT1u62xxZFiyTR3VoMasIJe9k6+Gb5kCLGLuHN6y2kmxKKfOScYQmNHhJmr+l0tu3bHqiyN5hEI520dXGTno6Ja7WICo87Q4bpjHlBMrwAaDq1JZu7sI0nVqWB9airp2y4h6gVqva3UXl5uNSpf1UnVkBz/+Zn1Te9ima2w=">https://www.dropbox.com/scl/fi/0tf3fmjxvks2wv01gz4zu/ARPA-H-CATALYST-Notes.docx?rlkey=u7cv91de7spjrbitzxrxqjark&st=kcj8b5br&dl=0</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none">If you have any questions or would like to get involved, please send me at
<a href="mailto:zhe@fsu.edu">zhe@fsu.edu</a> and Nicole Viverito at <a href="mailto:nviverito@fsu.edu">
nviverito@fsu.edu</a>. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">Sincerely,<o:p></o:p></span></p>
<div>
<div>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none">Best<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;mso-ligatures:none">Zhe<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">--<o:p></o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse">
<tbody>
<tr>
<td width="312" valign="top" style="width:233.75pt;padding:0in 5.4pt 0in 5.4pt">
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:#782F40;mso-ligatures:none"> </span><b><span style="font-size:11.0pt;font-family:"Cambria",serif;color:#782F40;mso-ligatures:none">Zhe He, PhD, FAMIA</span></b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">Interim Director, Institute for Successful Longevity (Administrative Assistant: Nehja Guillaume [</span><a href="mailto:ng24k@fsu.edu"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:#0563C1;mso-ligatures:none">ng24k@fsu.edu</span></a><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">])<br>
Associate Professor, School of Information</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">Director of UF-FSU Clinical and Translational Science Award Biostatistics, Informatics, and Research Design Program (UF-FSU CTSA BIRD) (</span><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fredcap.med.fsu.edu%2Fsurveys%2F%3Fs%3DRECYDF8P9AY7JHFW&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946584800%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=Xc5OjR4cP%2BNPfYGd0zKW0PvbnKL%2FglIlwY1xOuih4MY%3D&reserved=0" originalsrc="https://redcap.med.fsu.edu/surveys/?s=RECYDF8P9AY7JHFW" shash="ZYeceYRukbtfqGHbBTqVT+wINe3U8LxO48dsfX50KlY2JqiCoqMHvGb0jsUbgMNosfz98OzwN2DZ1wCw0FBcpqW4tTxaft+py5XvP1Xpjrbzarix3Gcgf2UnczNvkhlXcSsYzAoIbEyiJ2gNZhDyZjWQU5ePCev66e3/Sfdnz6o="><span style="font-size:10.0pt;font-family:"Cambria",serif;color:#0563C1;mso-ligatures:none">CTSA
 Service Request Form</span></a><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">)</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none"><br>
Florida State University<br>
142 Collegiate Loop</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">Louis Shores Building, Room 271<br>
Tallahassee, FL 32306</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">C: 646.789.3008</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">P: 850.644.5775</span><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none">Website: </span><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fsites.google.com%2Fsite%2Fhenryhezhe2003&data=05%7C02%7Cisl%40lists.fsu.edu%7Cef0c2b48f7e74679160108dcfe8078b9%7Ca36450ebdb0642a78d1b026719f701e3%7C0%7C0%7C638665074946584800%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=tIi31L4C6jDlKCBidy7IsL%2BHVqNHcgOSlGiQcqGjT5I%3D&reserved=0" originalsrc="https://sites.google.com/site/henryhezhe2003" shash="kRva1zJmXstNGUcaOl7zatqFEsH6T7Ia87dEWrirotJk9txWI2Tutr3i9eIct7yUFfRE/D4vidvP90kqulU59F2SW3SGILdOTUTqdzxMl70BalihqrC2P/gAzc7IUgqltTZqPicBDQy1jkg/bHF6akBY+MnkpuINPK0tz4f40Bk=" title="https://sites.google.com/site/henryhezhe2003"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:#0078D7;mso-ligatures:none">https://sites.google.com/site/henryhezhe2003</span></a><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
</td>
<td width="312" valign="top" style="width:233.75pt;padding:0in 5.4pt 0in 5.4pt">
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none"><img border="0" width="175" height="83" style="width:1.8229in;height:.8645in" id="Picture_x0020_2" src="cid:image001.jpg@01DB303D.AC46A1D0" alt="A close-up of a logo

Description automatically generated"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Cambria",serif;color:black;mso-ligatures:none"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none">     <img border="0" width="117" height="124" style="width:1.2187in;height:1.2916in" id="Picture_x0020_1" src="cid:image002.jpg@01DB303D.AC46A1D0" alt="A logo with a letter on it

Description automatically generated"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p> </o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>